Copy
Press release - March 15, 2021
Tweet Tweet
Share Share
Forward Forward

Following two successful open calls, EHDEN launches the 3rd open call for SMEs to apply for training and certification on converting health data from various formats to the OMOP common data model.

 
Today, in Europe, we are challenged to generate insights and evidence from real world clinical data at scale, to support patients, clinicians, payers, regulators, governments, and the pharmaceutical industry in understanding wellbeing, disease, treatments, outcomes and new therapeutics and devices, let alone mandatory evidence requests. Unfortunately, such data is difficult to use at scale, in a myriad of languages, systems and structures, with challenging policy restrictions and technology considerations, especially in Europe, currently demonstrated unfortunately by the COVID-19 pandemic.

In response to this, the EHDEN public-private project was set up in 2018 for 66 months under the framework of IMI2, with twenty-two partners, including academia, SMEs, patient associations, regulatory authorities and pharmaceutical companies, led by Erasmus Medical Centre, The Netherlands, and Janssen Pharmaceutica N.V., Belgium. The ultimate aim is to be sustainable beyond the original 66 months, and the project will be launching an EHDEN Institute in 2021.

The mission of EHDEN is to provide a new paradigm for the discovery and analysis of health data throughout Europe, by building a large-scale, federated network of data sources harmonised to the OMOP common data model, with standardised analytical pipelines. The aim is to harmonise more than 100 million health records utilising the services of EHDEN-certified SMEs to conduct the mapping working with the data source locally. EHDEN has previously conducted two open calls to invite SMEs to be certified by the project, and 3 open calls for data sources to apply for a capped grant to support the mapping work with EHDEN certified SMEs. As of today, EHDEN is currently working with 61 Data Partners in 16 countries, and 26 SMEs in 14 countries across Europe.

To further extend our network of certified SMEs, we are now launching the 3rd open call for SMEs to apply for training and certification to convert health data from various formats to the OMOP common data model. This 3rd open call will run from Monday 15th of March until Monday 12th of April (17h00 CET).

By becoming a certified SME in the EHDEN community you can:
  • Expand your existing market:
    • Customer base and geographical reach
    • Range of services and products
  • Contribute to the creation of emerging, new markets for data sciences
    • Health data mapping to the OMOP CDM
    • Data analysis services for small and medium biomedical companies
    • Infrastructure design and deployment
    • Enabler of high throughput studies by bridging data users and providers
    • Training on the use of OHDSI tools and observational analyses
    • Ongoing support and maintenance of connected data and provided solutions
  • Gain a competitive advantage on specialised skill set as an early adopter
  • Potentially contribute to a change of paradigm benefitting health of citizens
  • Generate a short-term income to offset skill investment
  • Receive free training and certification
  • Become part of an open source community to further boost business opportunities
  • Have access to a thriving community facilitating hands-on training of new staff
  • Increase exposure and brand recognition with key stakeholders
If this exciting prospect interests you, visit our website for more details and to submit your application. The EHDEN Consortium is looking forward to your potential application and to collaborate with you.
 
Website
Twitter
LinkedIn
YouTube
GitHub
Email
Visit our website to subscribe to our newsletter !
Copyright © EHDEN, All rights reserved.

Disclaimer
This newsletter reflects the views of the EHDEN consortium and neither IMI nor the European Union and EFPIA are liable for any use that may be made of the information contained herein.

Acknowledgement
The European Health Data & Evidence Network has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 806968. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
 
Want to change how you receive these emails?
You can
update your preferences or unsubscribe from this list.
 






This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
Ehden · X · X · X, B 08591 · Spain

Email Marketing Powered by Mailchimp